Keywords
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Indoles (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Indoles (pharmacology) < Indoles (therapeutic use) < Indonesia (epidemiology)  Facettes :

List of bibliographic references indexed by Indoles (therapeutic use)

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000294 (2021) Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde]One year update on the COVID-19 pandemic: Where are we now?
000507 (2021) Meng Wang [République populaire de Chine] ; Ting Wu [République populaire de Chine] ; Zhihong Zuo [République populaire de Chine] ; Yaxian You [République populaire de Chine] ; Xinyuan Yang [République populaire de Chine] ; Liangyu Pan [République populaire de Chine] ; Ying Hu [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Zanxian Xia [République populaire de Chine] ; Meichun Deng [République populaire de Chine]Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis.
000660 (2021) Jun Chen [République populaire de Chine] ; Danping Liu [République populaire de Chine] ; Lin Yin [République populaire de Chine] ; Lijun Zhang [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine]Can we use hydroxychloroquine to treat COVID-19 now?
000729 (2021) Ambedkar Kumar Yadav [République populaire de Chine] ; Siwan Wen [République populaire de Chine] ; Xianghuai Xu [République populaire de Chine] ; Li Yu [République populaire de Chine]Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
000762 (2021) Jiahong Tan [République populaire de Chine] ; Yuan Yuan [République populaire de Chine] ; Cheng Xu [République populaire de Chine] ; Chunyan Song [République populaire de Chine] ; Dan Liu [République populaire de Chine] ; Ding Ma [République populaire de Chine] ; Qinglei Gao [République populaire de Chine]A retrospective comparison of drugs against COVID-19.
000A47 (2020) Waquar Ahsan [Arabie saoudite] ; Shamama Javed [Arabie saoudite] ; Mohammed Al Bratty [Arabie saoudite] ; Hassan A. Alhazmi [Arabie saoudite] ; Asim Najmi [Arabie saoudite]Treatment of SARS-CoV-2: How far have we reached?
000E35 (2020) Saba Shamim [Pakistan] ; Maryam Khan [Pakistan] ; Zelal Jaber Kharaba [Émirats arabes unis] ; Munazza Ijaz [Pakistan] ; Ghulam Murtaza [Pakistan]Potential strategies for combating COVID-19.
000E46 (2020) N. Trivedi [États-Unis] ; A. Verma ; D. KumarPossible treatment and strategies for COVID-19: review and assessment.
000E64 (2020) James M. Sanders [États-Unis] ; Marguerite L. Monogue [États-Unis] ; Tomasz Z. Jodlowski [États-Unis] ; James B. Cutrell [États-Unis]Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
001376 (2020) Marzieh Nojomi [Iran] ; Zeynab Yassin [Iran] ; Hossein Keyvani [Iran] ; Mahin Jamshidi Makiani [Iran] ; Maryam Roham [Iran] ; Azadeh Laali [Iran] ; Nasir Dehghan [Iran] ; Mehrnaz Navaei [Iran] ; Mitra Ranjbar [Iran]Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial.
001453 (2020) Richard A. Giovane [États-Unis] ; Shadi Rezai [États-Unis] ; Ellen Cleland [États-Unis] ; Cassandra E. Henderson [États-Unis]Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
001886 (2020) Chang Li [République populaire de Chine] ; Lin Wang [République populaire de Chine] ; Linzhu Ren [République populaire de Chine]Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
001907 (2020) Dongyuan Wang [République populaire de Chine] ; Zigang Li [République populaire de Chine] ; Yihui Liu [République populaire de Chine]An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
001933 (2020) Yongtao Duan [République populaire de Chine] ; Hai-Liang Zhu [République populaire de Chine] ; Chongchen Zhou [République populaire de Chine]Advance of promising targets and agents against COVID-19 in China.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Indoles (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Indoles (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Indoles (therapeutic use)
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021